COMMUNIQUÉS West-GlobeNewswire

-
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global
27/06/2024 -
Comedian and Actor Drew “Druski” Desbordes Joins Safety Shot as Their Newest Brand Ambassador
27/06/2024 -
Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)
26/06/2024 -
Oragenics, Inc. Announces Closing of Public Offering
26/06/2024 -
Tonix Pharmaceuticals Announces Proposed Public Offering
26/06/2024 -
Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement
26/06/2024 -
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
26/06/2024 -
MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer
26/06/2024 -
Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
26/06/2024 -
Progyny, Inc. to Host 2024 Inaugural Investor Day
26/06/2024 -
Tevogen Bio Files Registration Statement for Previously Disclosed Securities; Does Not Relate to Any Previously Undisclosed New Issuances of Dilutive Securities
26/06/2024 -
SMISS Asia Pacific 2024 Congress and training program
26/06/2024 -
Congrès Asie Pacifique SMISS 2024 et programme de formation
26/06/2024 -
Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board
26/06/2024 -
Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale et la nomination d’un nouvel administrateur à son conseil d’administration
26/06/2024 -
EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth1
26/06/2024 -
EUROAPI poursuit sa transformation grâce au plan FOCUS-27 et pose les bases d’une future croissance rentable1
26/06/2024 -
Allergy Named Highest-Impact Journal in Allergy and Clinical Immunology for 2024
26/06/2024 -
CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change
26/06/2024
Pages